Assessment of chemical libraries for their druggability
暂无分享,去创建一个
Kuo-Chen Chou | Qishi Du | George E. Hatzakis | Dongqing Wei | Suzanne W. Sirois | K. Chou | Dongqing Wei | G. Hatzakis | S. Sirois | Q. Du
[1] W. Patrick Walters,et al. Filtering databases and chemical libraries , 2002, J. Comput. Aided Mol. Des..
[2] Tudor I. Oprea,et al. Property distribution of drug-related chemical databases* , 2000, J. Comput. Aided Mol. Des..
[3] Kuo-Chen Chou,et al. Using GO-PseAA predictor to predict enzyme sub-class. , 2004, Biochemical and biophysical research communications.
[4] Jürgen Bajorath,et al. Integration of virtual and high-throughput screening , 2002, Nature Reviews Drug Discovery.
[5] Brian Hudson,et al. Strategic Pooling of Compounds for High-Throughput Screening , 1999, J. Chem. Inf. Comput. Sci..
[6] Kuo-Chen Chou,et al. Prediction of the Tertiary Structure of the β-Secretase Zymogen☆ , 2002 .
[7] Kuo-Chen Chou,et al. Modelling extracellular domains of GABA-A receptors: subtypes 1, 2, 3, and 5. , 2004, Biochemical and biophysical research communications.
[8] K. Chou. Applications of graph theory to enzyme kinetics and protein folding kinetics. Steady and non-steady-state systems. , 2020, Biophysical chemistry.
[9] Kuo-Chen Chou,et al. Insights from modelling the 3D structure of the extracellular domain of alpha7 nicotinic acetylcholine receptor. , 2004, Biochemical and biophysical research communications.
[10] K. Chou. Graphic rules in steady and non-steady state enzyme kinetics. , 1989, The Journal of biological chemistry.
[11] Kuo-Chen Chou,et al. Prediction of the tertiary structure of the beta-secretase zymogen. , 2002, Biochemical and biophysical research communications.
[12] Peter Ertl,et al. Cheminformatics Analysis of Organic Substituents: Identification of the Most Common Substituents, Calculation of Substituent Properties, and Automatic Identification of Drug-like Bioisosteric Groups , 2003, J. Chem. Inf. Comput. Sci..
[13] Miklos Feher,et al. Property Distributions: Differences between Drugs, Natural Products, and Molecules from Combinatorial Chemistry , 2003, J. Chem. Inf. Comput. Sci..
[14] H. Kubinyi,et al. A scoring scheme for discriminating between drugs and nondrugs. , 1998, Journal of medicinal chemistry.
[15] Kuo-Chen Chou,et al. Binding mechanism of coronavirus main proteinase with ligands and its implication to drug design against SARS , 2003, Biochemical and Biophysical Research Communications.
[16] Ajay,et al. Can we learn to distinguish between "drug-like" and "nondrug-like" molecules? , 1998, Journal of medicinal chemistry.
[17] Darren V. S. Green,et al. Implementation of a System for Reagent Selection and Library Enumeration, Profiling, and Design , 1999, J. Chem. Inf. Comput. Sci..
[18] K. Chou. Prediction of human immunodeficiency virus protease cleavage sites in proteins. , 1996, Analytical biochemistry.
[19] Kuo-Chen Chou. Insights from modelling the 3 D structure of the extracellular domain of a 7 nicotinic acetylcholine receptor q , 2004 .
[20] G. Rishton. Nonleadlikeness and leadlikeness in biochemical screening. , 2003, Drug discovery today.
[21] Kuo-Chen Chou,et al. Prediction of enzyme family classes. , 2003, Journal of proteome research.
[22] P. Leeson,et al. A comparison of physiochemical property profiles of development and marketed oral drugs. , 2003, Journal of medicinal chemistry.
[23] G. Rishton. Reactive compounds and in vitro false positives in HTS , 1997 .
[24] Gordon M. Crippen,et al. Prediction of Physicochemical Parameters by Atomic Contributions , 1999, J. Chem. Inf. Comput. Sci..
[25] C. Lipinski. Drug-like properties and the causes of poor solubility and poor permeability. , 2000, Journal of pharmacological and toxicological methods.
[26] F. Lombardo,et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings , 1997 .
[27] B. Shoichet,et al. A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening. , 2002, Journal of medicinal chemistry.
[28] Tudor I. Oprea,et al. Is There a Difference between Leads and Drugs? A Historical Perspective , 2001, J. Chem. Inf. Comput. Sci..
[29] Nicolas Baurin. Etude et développement de techniques QSAR pour la recherche de molécules d'intérêt thérapeutique : criblage virtuel et analyse de chimiothèques , 2002 .
[30] Kuo-Chen Chou,et al. A novel approach to predict active sites of enzyme molecules , 2004, Proteins.
[31] K. Chou,et al. Using Functional Domain Composition and Support Vector Machines for Prediction of Protein Subcellular Location* , 2002, The Journal of Biological Chemistry.
[32] Kuo-Chen Chou,et al. Prediction and classification of protein subcellular location—sequence‐order effect and pseudo amino acid composition , 2003, Journal of cellular biochemistry.
[33] K. Chou,et al. Prediction of the tertiary structure and substrate binding site of caspase‐8 , 1997, FEBS letters.
[34] Tudor I. Oprea,et al. The Design of Leadlike Combinatorial Libraries. , 1999, Angewandte Chemie.
[35] Kuo-Chen Chou,et al. Predicting enzyme family class in a hybridization space , 2004, Protein science : a publication of the Protein Society.
[36] K. Chou,et al. Bioinformatical analysis of G-protein-coupled receptors. , 2002, Journal of proteome research.
[37] Kuo-Chen Chou. Insights from modeling three-dimensional structures of the human potassium and sodium channels. , 2004, Journal of proteome research.
[38] Arthur Dalby,et al. Description of several chemical structure file formats used by computer programs developed at Molecular Design Limited , 1992, J. Chem. Inf. Comput. Sci..
[39] G. Zhou,et al. An extension of Chou's graphic rules for deriving enzyme kinetic equations to systems involving parallel reaction pathways. , 1984, The Biochemical journal.
[40] B. Stockwell,et al. Biological mechanism profiling using an annotated compound library. , 2003, Chemistry & biology.
[41] K. Chou,et al. A vectorized sequence-coupling model for predicting HIV protease cleavage sites in proteins. , 1993, The Journal of biological chemistry.
[42] Wolfgang Guba,et al. Development of a virtual screening method for identification of "frequent hitters" in compound libraries. , 2002, Journal of medicinal chemistry.
[43] K. Chou. Structural bioinformatics and its impact to biomedical science. , 2004, Current medicinal chemistry.
[44] K D Watenpaugh,et al. A model of the complex between cyclin-dependent kinase 5 and the activation domain of neuronal Cdk5 activator. , 1999, Biochemical and biophysical research communications.
[45] C. Zhang,et al. Diagrammatization of codon usage in 339 human immunodeficiency virus proteins and its biological implication. , 1992, AIDS research and human retroviruses.
[46] Jun Xu,et al. Drug-like Index: A New Approach To Measure Drug-like Compounds and Their Diversity , 2000, J. Chem. Inf. Comput. Sci..
[47] Kuo-Chen Chou,et al. Virtual Screening for SARS-CoV Protease Based on KZ7088 Pharmacophore Points , 2004, J. Chem. Inf. Model..
[48] K C Chou,et al. Kinetics of processive nucleic acid polymerases and nucleases. , 1994, Analytical biochemistry.